| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $446K | +5.3% | -83.9% |
| SG&A Expense | $528K | -42.6% | -68.9% |
| Operating Income | -$528K | +69.8% | +88.2% |
| Pre-tax Income | -$473K | +54.7% | +90.3% |
| Income Tax | -$3.0M | — | — |
| Net Income | -$473K | +54.7% | +90.3% |
| EPS (Basic) | -$0.04 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $3.7M | -17.0% | +5.9% |
| Total Assets | $3.7M | -17.0% | +0.7% |
| Current Liabilities | $347K | -41.4% | -87.2% |
| Total Liabilities | $416K | -41.3% | -89.9% |
| Stockholders' Equity | $3.3M | -12.4% | +917.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | — |
| Investing Cash Flow | -$132K | — | — |
| Financing Cash Flow | $5.0M | — | — |
| +94.4% |
| EPS (Diluted) | -$0.04 | +55.6% | +94.4% |